Published on January 05, 2021

Costa Rica : Health Alert Counterfeit drug detected in Mexico: Ivermectin



On November 20, 2020, the Directorate of Regulation of Products of Health Interest received an alert on counterfeit medicine Ivermectin detected in Mexico by the Network to Combat Substandard and Counterfeit Medical Products of the Pan American Health Organization. Because the alert is about a product that is registered in Costa Rica, the data of the alert is communicated.  It is important to mention that to date no such counterfeit has been detected in the national territory. However, surveillance and product control activities in the market are maintained for the timely detection of national cases.  In Costa Rica, the medicine Ivexterm is registered under number 1007-DN-2038 in a box with 2 tablets manufactured by Laboratorios Servet S.A. de C.V. of Mexico for Laboratorios Grossman S.A. of Mexico.

Name and description of the counterfeit product: COFEPRIS has carried out an investigation based on a complaint by Laboratorios Grossman S.A. Ivermectina tablets 6mg, lot No. 382820, expiration date 22 DIC 2022, bottle 4 tablets, without sanitary registration.  Ivermin tablets 6mg, lot No. SC2025, expiration date JUN 2023, bottle 4 tablets, sanitary register 566M2001 SSA IV (this is a register of COFEPRIS that belongs to the medicine Ivexterm in box presentation 2, 4, 6 or 100 tablets.

Ministry of Health Directorate of Regulation of Products of Health Interest.  It should be remembered that Article 107 of the General Health Law No. 5395 states: "It is forbidden to import, manufacture, trade, distribute or supply in any way, manipulate, use, consume or have for trade, deteriorated, adulterated or counterfeit medicines

Recommendations to the population -Buy medicines only from authorized distributors and in establishments that have a Health Permit from the Ministry of Health. -Verify the health registration of medicines on the platform Register it available at Report to the Ministry of Health any suspicion of marketing counterfeit medicines at or in the nearest Health Governing Area. Report if a medicine has caused health problems to the National Center of Pharmacovigilance through the platform Noti-FACEDRA available at

Subscribe to receive the latest news